Search

Your search keyword '"Corsico, Angelo"' showing total 243 results

Search Constraints

Start Over You searched for: Author "Corsico, Angelo" Remove constraint Author: "Corsico, Angelo" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
243 results on '"Corsico, Angelo"'

Search Results

1. OS-120 Fazirsiran reduces liver Z-alpha-1 antitrypsin synthesis, decreases globule burden and improves histological measures of liver disease in adults with alpha-1 antitrypsin deficiency: a randomized placebo-controlled phase 2 study

2. Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA)

3. Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: The ICSLIFE pragmatic, randomised controlled study

4. Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort

5. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

6. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

9. Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry

10. Early life exposures contributing to accelerated lung function decline in adulthood – a follow-up study of 11,000 adults from the general population

11. Performance of an AI algorithm during the different phases of the COVID pandemics: what can we learn from the AI and vice versa.

12. Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus

13. Long-term residential exposure to air pollution and risk of chronic respiratory diseases in Italy: The BIGEPI study

15. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

16. Bayesian Networks in the Management of Hospital Admissions: A Comparison between Explainable AI and Black Box AI during the Pandemic

19. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

21. Quantification of circulating alpha-1-antitrypsin polymers associated with different SERPINA1 genotypes.

22. An Underestimated Cause of Hemoptysis in a 41-Year-Old Man.

23. Phenotypes and Serum Biomarkers in Sarcoidosis

24. Improving the diagnosis of AATD with aid of serum protein electrophoresis: a prospective, multicentre, validation study

25. Exacerbation Burden in COPD and Occurrence of Mortality in a Cohort of Italian Patients: Results of the Gulp Study

26. Diagnostic delay in bronchiectasis: an Italian perspective

27. Severe asthma: One disease and multiple definitions

28. Early life exposures contributing to accelerated lung function decline in adulthood : a follow-up study of 11,000 adults from the general population

29. Exacerbation Burden in COPD and Occurrence of Mortality in a Cohort of Italian Patients: Results of the Gulp Study

31. Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis.

32. Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project.

33. Adjuvant Surgical Treatment of Non-Tuberculous Mycobacterial Lung Disease in Chronic Thromboembolic Pulmonary Hypertension: A First Case Report

34. Incidence of Tracheal Stenosis in ICU Hospitalized COVID-19 Patients: Results from a Prospective, Observational, Multicenter Study

35. Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease

36. Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients

39. Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease.

40. Spirometric patterns in young and middle-aged adults: a 20-year European study

41. Clinical profile in patients with severe alpha-1 antitrypsin deficiency due to rare genotypes

44. Smoking and hypersensitivity pneumonitis: a single Institution retrospective analysis

46. Quality of life following CAP hospitalization: preliminary results from the PNEUMO study Europe

50. Fazirsiran reduces liver Z-alpha-1 antitrypsin synthesis, decreases globule burden and improves histological measures of liver disease in adults with alpha-1 antitrypsin deficiency: a randomized placebo-controlled phase 2 study

Catalog

Books, media, physical & digital resources